Nanoparticle tracking analysis

Show results for

Unknown (1082)
Proteomics (117)
Genomics (105)
Transcriptomics (30)
Metabolomics (3)
Other (1)

Organisms

Allexis (97)
Arabidopsis thaliana (97)
Bos taurus (97)
Callinectes sapidus (97)
Drosophila melanogaster (97)
Entamoeba histolytica HM-1:IMSS-A (97)
Escherichia coli (97)
Homo sapiens (97)
Leishmania major strain Friedlin (97)
Listeria monocytogenes (97)
Medicago truncatula (97)
Meleagris gallopavo (97)
Methylohalobius crimeensis 10Ki (97)
Mus musculus (97)
Homo sapiens (48)
Mus musculus (19)
Bos taurus (3)
Haemaphysalis longicornis (2)
Cervus nippon (1)
Giardia duodenalis (1)
synthetic construct (1)
Capra hircus (1)
Danio rerio (1)
Sus scrofa (1)
Rattus norvegicus (1)
Enterococcus faecalis OG1RF (1)
Ligilactobacillus salivarius (1)
Spirometra erinaceieuropaei (1)
Sus scrofa domesticus (1)
Talaromyces marneffei (1)

Organisms

Homo sapiens (34)
Mus musculus (10)
Rattus norvegicus (2)
Bos taurus (2)
Cervus nippon (1)
Giardia duodenalis (1)
Sus scrofa (1)
Danio rerio (1)

Repository

pride (97)
ENA (73)
geo (48)
biostudies-arrayexpress (15)
iProX (15)
MassIVE (3)
jPOST (2)
MetaboLights (2)
GNPS (1)

Tissue

Blood plasma (19)
Cell culture (18)
Extracellular vesicle (7)
Blood serum (5)
Urine (4)
Blood cell (3)
Epithelial cell (3)
Macrophage (3)
Blood (2)
Brain (2)
Cerebrospinal fluid (2)
Heart (2)
Permanent cell line cell (2)
Placenta (2)
Platelet (2)
T cell (2)
Acute myeloid leukemia cell line (1)
Amniotic fluid (1)
Astrocyte (1)
B cell (1)
Blood platelet (1)
Bone marrow (1)
Bone marrow cell (1)
Breast cancer cell line (1)
Carotid atherosclerotic plaque (1)
Cell suspension culture (1)
Colon (1)
Colon endothelium (1)
Colostrum (1)
HUVEC cell (1)

Disease

Disease free (4)
Brain glioblastoma multiforme (2)
Lung cancer (2)
Type 2 diabetes mellitus (2)
Acute myeloid leukemia (1)
Alzheimer's disease (1)
Amyotrophic lateral sclerosis type 1 (1)
Atherosclerosis (1)
Autism spectrum disorder (1)
Babesiosis (1)
Brain cancer (1)
Breast cancer (1)
COVID-19 (1)
Cerebrovascular disease (1)
Chagas disease (1)
Chronic kidney disease (1)
Colon cancer (1)
Diabetes mellitus (1)
Endometritis (1)
Heart disease (1)
Heart failure (1)
Intracerebral hemorrhage (1)
Leishmaniasis (1)
Liver disease (1)
Mixed disorder as reaction to stress (1)
Multiple myeloma (1)
Myopia (1)
Oral cavity (1)
Pancreas adenocarcinoma (1)
Wounds and Injuries (1)

Technology Type

Mass Spectrometry (97)
Shotgun proteomics (39)
Bottom-up proteomics (36)
Data-dependent acquisition (19)
Data-independent acquisition (11)
SWATH MS (5)
Gel-based experiment (3)
Mass spectrometry assay (2)
Affinity purification coupled with mass spectrometry proteomics (2)
MSE (2)
Top-down proteomics (2)
Affinity proteomics (1)
DiaPASEF (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - reverse phase (2)
NextSeq 550 (1)
Illumina HiSeq 2500 (1)
NextSeq 500 (1)
7890A GC coupled to a 5975C inert XL MSD, with a 7683 series injector (G2614A) (1)
LTQ Orbitrap Velos (1)
Orbitrap Fusion (1)
Orbitrap Fusion Tribrid (Thermo Scientific instrument model) (1)
TripleTOF 5600 (1)

Publication Date

2026 (38)
2025 (35)
2023 (29)
2024 (22)
2022 (16)
2021 (13)
2020 (10)
2017 (3)
2016 (3)
2013 (3)
2018 (3)
2015 (2)
2014 (2)
2019 (2)
2009 (1)

Metabolite Name

VAE 27:1 (1)
TG O-64:10|TG O-20:0_22:5_22:5 (1)
TG O-62:9|TG O-18:0_22:4_22:5 (1)
TG O-62:8|TG O-18:0_22:4_22:4 (1)
TG O-62:7|TG O-22:1_18:1_22:5 (1)
TG O-62:6|TG O-22:0_18:1_22:5 (1)
TG O-62:3|TG O-18:1_22:1_22:1 (1)
TG O-62:2|TG O-18:0_22:1_22:1 (1)
TG O-62:12|TG O-18:1_22:5_22:6 (1)
TG O-62:11|TG O-18:0_22:5_22:6 (1)
TG O-62:10|TG O-18:0_22:5_22:5 (1)
TG O-62:1|TG O-18:0_22:0_22:1 (1)
TG O-61:2|TG O-22:0_17:1_22:1 (1)
TG O-60:9|TG O-16:0_22:4_22:5 (1)
TG O-60:8|TG O-18:0_20:4_22:4 (1)
TG O-60:7|TG O-22:1_16:0_22:6 (1)
TG O-60:6|TG O-22:1_16:0_22:5 (1)
TG O-60:5|TG O-22:0_16:0_22:5 (1)
TG O-60:4|TG O-18:1_20:1_22:2 (1)
TG O-60:3|TG O-18:1_20:1_22:1 (1)
TG O-60:2|TG O-18:0_20:1_22:1 (1)
TG O-60:11|TG O-16:0_22:5_22:6 (1)
TG O-60:10|TG O-16:0_22:5_22:5 (1)
TG O-60:1|TG O-18:0_20:0_22:1 (1)
TG O-59:5|TG O-21:0_16:0_22:5 (1)
TG O-59:3|TG O-18:0_20:1_21:2 (1)
TG O-59:2|TG O-17:0_20:1_22:1 (1)
TG O-58:9|TG O-16:0_20:4_22:5 (1)
TG O-58:8|TG O-22:6_18:1_18:1 (1)
TG O-58:8|TG O-18:1_18:1_22:6 (1)

First Public Date

2025 (19)
2026 (17)
2022 (10)
2024 (8)
2023 (6)
2021 (4)
2020 (4)
2019 (1)
2017 (1)
2016 (1)
2015 (1)
2014 (1)

Classification

protozoa (1)

Study type

Transcription profiling by array (7)
Other (3)
Bisulfite-seq (1)
MicroRNA profiling by array (1)
RNA-seq of total RNA (1)
RNA-seq of coding RNA (1)
RNA-seq of non coding RNA (1)

Release Date

2025 (183)
2022 (152)
2023 (146)
2021 (146)
2020 (122)
2024 (116)
2019 (61)
2018 (51)
2017 (29)
2026 (25)
2015 (22)
2016 (19)
2014 (13)
2013 (4)
2012 (4)
2009 (1)
2011 (1)
2010 (1)
2008 (1)

Lab affiliation

1VIB-UGent Center for Medical Biotechnology, VIB, 9052 Ghent, Belgium 2Department of Biomolecular Medicine, Ghent University, 9052 Ghent, Belgium (3)
Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK (2)
Head of Proteomics (2)
ICM, Molecular Evolution, Uppsala University (2)
Instituto de Investigaciones Sanitarias de Santiago de Compostela (2)
1 - i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135 Porto, Portugal; 2 - Cancer Drug Resistance Group, IPATIMUP – Institute of Molecular Pathology and Immunology, University of Porto, Rua Júlio Amaral de Carvalho 45, 4200-135 Porto, Portugal; 3 - Department of Biological Sciences, FFUP – Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal (1)
1. Gene Regulation, Stem Cells and Development group, PTS, Granada GENyO, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research, Avenida de la Ilustración 114, 18016 Granada, Spain. 2. Department of Biochemistry and Molecular Biology I, Faculty of Science, University of Granada, Avenida Fuentenueva s/n, 18071 Granada, Spain. 3. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. (1)
Academic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabo-lism, The Medical School, University of Sheffield, Sheffield , UK And Department of Pathophysiology, Institute of Biomedicine and Translational Medicine, Faculty of Medi-cine, University of Tartu, 14B Ravila, 50411 Tartu, Estonia and Institute of Veterinary Medicine and Animal Sciences, Estonian University of Life Sciences (1)
Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Department of Digital Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS), Technical University of Munich (TUM), Freising, Germany (1)
Bavarian Center for Biomolecular Mass Spectrometry at Klinikum rechts der Isar (BayBioMS@MRI), TUM School of Medicine and Health, Technical University of Munich (TUM), 81675 München, Germany (1)
Bavarian Center for Biomolecular Mass Spectrometry, Freising, TU Munich (1)
Biological Mass Spectrometry Lab, Department of Translational Medicine, University of Piemonte Orientale (1)
CRG-UPF (1)
Center for Regeneration and Aging,BGI-haangzhou (1)
Computational and Experimental Biology Group, CEDOC, Chronic Diseases Research Centre, NOVA Medical School, Faculdade de Ciencias Medicas, Universidade NOVA de Lisboa, Campo dos Martires da Patria, 130, 1169-056 Lisboa, Portugal (1)
Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Göttingen, Germany (1)
DZNE Munich Neuroproteomics Feodor-Lynen-Str. 17 81377 Munich Germany (1)
Departament de Bioquímica i Biologia Molecular, Facultat de Ciències Biològiques, Universitat de València, Burjassot (Valencia), Spain (1)
Departamento de Biología de Sistemas, Universidad de Alcalá, 28871 Alcala de Henares, Madrid, Spain (1)
Department of Animal and Aquaculture Sciences, Faculty of Biosciences, Norwegian University of Life Sciences, Aas, Norway (1)
Department of Biochemistry, Soonchunhyang University, College of Medicine, Cheonan, 31151, Republic of Korea (1)
Department of Biological Sciences, Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX USA (1)
Department of Biology, Chair of Molecular Genetics and Microbiology, University of Ljubljana, Slovenia (1)
Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland (1)
Department of Clinical Laboratory The Second Affiliated Hospital Guizhou University of Traditional Chinese Medicine (1)
Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute of infectious diseases IRCCS Lazzaro Spallanzani, Rome (1)
Department of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. (1)
Department of Large Animals Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 166, 02-787, Warsaw, Poland (1)
Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand (1)

Previous page
1 / 134
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 134
Next page

Sort by:

Relevance

Page size

Integrated Multi-Omics Landscape of non-small cell lung cancer with distant metastasis

we collected BALF from patients with metastatic and non-metastatic NSCLC to isolate exosomes, which were then characterized by nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM), followed by comprehensive metabolomic and proteomic analysis.

ORGANISM(S): Homo Sapiens

2025-03-13 | PXD061819 |

Dark field nanoparticle tracking analysis for size characterization of plasmonic and non-plasmonic particles.

Not available

S-EPMC4021069 | biostudies-literature

Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis.

Not available

S-EPMC3280380 | biostudies-literature

Lipidomic analysis of Toxoplasma gondii extracellular vesicles across host cell types

Introduction. Toxoplasma gondii is an obligate intracellular parasite with an exceptional capacity to colonize a broad range of host species and cell types. Successful infection depends on its ability to manipulate host metabolism, including lipid pathways that are essential for membrane biogenes...

2026-02-11 | MTBLS13253 | MetaboLights

Rabies Vaccine Characterization by Nanoparticle Tracking Analysis.

Not available

S-EPMC7235079 | biostudies-literature

Concentration and size distribution data of silicon nitride nanoparticles measured using nanoparticle tracking analysis.

Not available

S-EPMC5675993 | biostudies-literature

Effects of labelling fetal MSC with MRI Particles: MGIO and Ferucarbotran

Cell tracking is enabled by incubating ex vivo cells with commercially/clinically available MRI particulate label, such as ferucarbotran. However, the uptake by non-phagocytic cells, such as mesenchymal stem cell (MSC) is poor, and the detection by MRI is impeded. MGIO is a new label that is efficie...

ORGANISM(S): Homo sapiens

2009-02-08 | E-GEOD-13975 | biostudies-arrayexpress

Simultaneous Electro-Optical Tracking for Nanoparticle Recognition and Counting.

Not available

S-EPMC5146980 | biostudies-literature

High throughput nanoparticle tracking analysis for monitoring outer membrane vesicle production.

Not available

S-EPMC5505008 | biostudies-literature

Extracellular Vesicles in acute coronary syndrome: carrier of epigenetics marks

Background: Acute coronary syndromes (ACS) are associated with aberrant gene expression and epigenetic mechanisms. In particular, de novo DNA methylation is typically linked to gene silencing, but its role in heart disease remains not fully understood. Extracellular vesicles (EVs) are active compon...

ORGANISM(S): Homo sapiens

2023-04-03 | E-MTAB-11641 | biostudies-arrayexpress

Previous page
1 / 134
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 134
Next page

Sort by:

Relevance

Page size

1338 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets